Lip GY - Search Results

1

Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?

Ntaios G, Papavasileiou V, Lip GY, Milionis H, Makaritsis K, Vemmou A, Koroboki E, Manios E, Spengos K, Michel P, Vemmos K. Ntaios G, et al. Among authors: lip gy. J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2975-2980. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.015. Epub 2016 Sep 6. J Stroke Cerebrovasc Dis. 2016. PMID: 27612625

2

Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project.

Lip GY, Kamath S, Jafri M, Mohammed A, Bareford D. Lip GY, et al. Stroke. 2002 Jan;33(1):238-42. doi: 10.1161/hs0102.101817. Stroke. 2002. PMID: 11779916

3

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Chung NA, et al. Among authors: lip gy. Stroke. 2002 Sep;33(9):2187-91. doi: 10.1161/01.str.0000023889.84649.3d. Stroke. 2002. PMID: 12215585 Clinical Trial.

4

Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.

Conway DS, Heeringa J, Van Der Kuip DA, Chin BS, Hofman A, Witteman JC, Lip GY. Conway DS, et al. Among authors: lip gy. Stroke. 2003 Feb;34(2):413-7. doi: 10.1161/01.str.0000051728.85133.32. Stroke. 2003. PMID: 12574552

5

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Among authors: lip gy. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

6

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ. Lip GY, et al. Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13. Heart. 2006. PMID: 16159980 Free PMC article. Review.

7

Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.

Lip GY, Lane D, Van Walraven C, Hart RG. Lip GY, et al. Stroke. 2006 Sep;37(9):2294-300. doi: 10.1161/01.STR.0000236840.00467.84. Epub 2006 Aug 3. Stroke. 2006. PMID: 16888271

8

Management of atrial fibrillation.

Watson T, Lip GY. Watson T, et al. Among authors: lip gy. Herz. 2006 Dec;31(9):849-56. doi: 10.1007/s00059-006-2932-5. Herz. 2006. PMID: 17180647 Review.

9

High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.

Lip GY, Patel JV, Hughes E, Hart RG. Lip GY, et al. Stroke. 2007 Apr;38(4):1229-37. doi: 10.1161/01.STR.0000260090.90508.3e. Epub 2007 Mar 1. Stroke. 2007. PMID: 17332453

10

Modern management of atrial fibrillation.

Watson T, Shanstila E, Lip GY. Watson T, et al. Among authors: lip gy. Clin Med (Lond). 2007 Jan-Feb;7(1):28-34. doi: 10.7861/clinmedicine.7-1-28. Clin Med (Lond). 2007. PMID: 17348571 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,162 results

Search Page

Filters